Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506774 | SCV000604154 | benign | not specified | 2018-07-03 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000506774 | SCV000707506 | benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001510535 | SCV001717593 | benign | Familial Mediterranean fever | 2022-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533513 | SCV001750191 | benign | Familial Mediterranean fever, autosomal dominant | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001510535 | SCV001750192 | benign | Familial Mediterranean fever | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000870512 | SCV001896894 | benign | not provided | 2018-06-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27659338) |
Unidad de Genómica Garrahan, |
RCV000506774 | SCV004101862 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 80% of patients studied by a panel of primary immunodeficiencies. Number of patients: 77. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000870512 | SCV005293861 | benign | not provided | criteria provided, single submitter | not provided |